Who owns ROCKET PHARMACEUTICALS INC?
- Ticker: RCKTW
- CUSIP Number: 77313f114
Tip: Access positions for across all investors
Analyze quarterly positions in Rocket Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Rocket Pharmaceuticals stock
Who bought or sold ROCKET PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sio Capital Management | 400k | $1.5k | 0% | Jun 2026 |
|
| Rtw Investments | 350k | $1.2k | 0% | Jun 2026 |
|
| Citadel Advisors | 310k | $1.9k | 0% | Jun 2026 |
|
| Walleye Trading Advisors | 284k | $1.4k | 0% | Jun 2026 |
|
| Silverarc Capital Management | 105k | $356.415200 | 0% | Jun 2026 |
|
| LMR Partners | 76k | $363.508800 | 0% | Jun 2026 |
|
| Affinity Asset Advisors | 75k | $277.500000 | 0% | Jun 2026 |
|
| Boothbay Fund Management | 37k | $126k | 0% | Jun 2026 |
|
| Ancora Advisors | 6.0k | $22.200000 | 0% | Jun 2026 |
|
| Clear Street Group | 99.00 | $0 | 100% | Jun 2026 |
|
| Toronto-Dominion Bank | 99.00 | $48.995100 | 100% | Jun 2026 |
|
Who sold out of Rocket Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Mar 2026 | 4.0k | $83.999100 |